Atomoxetine (Strattera) and suicidality in children and adolescents

SHARE VIA:

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Important warning from TGA re atomoxetine (Strattera) – most commonly prescribed for ADHD.

Serious adverse events reported to the TGA, including one case involving the death of a child, reinforce the importance of health professionals adequately informing parents and caregivers of the risks of suicidal ideation and behaviour in children and adolescents being prescribed atomoxetine (Strattera).

More at

https://www.tga.gov.au/hp/msu-2013-05.htm#atomoxetine

Cheers

Mike

About the authors

KEEP READING

High flow therapy – when and how?

Chest compressions in traumatic cardiac arrest

Searching for sepsis

The missing link? Children and transmission of SARS-CoV-2

Don’t Forget the Brain Busters – Round 2

An evidence summary of Paediatric COVID-19 literature

Urticaria

The fidget spinner craze – the good, the bad and the ugly

Parenteral Nutrition

Leave a Reply

Your email address will not be published. Required fields are marked *